PMID- 21861923 OWN - NLM STAT- MEDLINE DCOM- 20120123 LR - 20211020 IS - 1471-2377 (Electronic) IS - 1471-2377 (Linking) VI - 11 DP - 2011 Aug 24 TI - The determinants of stroke phenotypes were different from the predictors (CHADS2 and CHA2DS2-VASc) of stroke in patients with atrial fibrillation: a comprehensive approach. PG - 107 LID - 10.1186/1471-2377-11-107 [doi] AB - BACKGROUND: Atrial fibrillation (AF) is a leading cause of fatal ischemic stroke. It was recently reported that international normalized ratio (INR) levels were associated with infarct volumes. However, factors other than INR levels that affect stroke phenotypes are largely unknown. Therefore, we evaluated the determinants of stroke phenotypes (pattern and volume) among patients with AF who were not adequately anticoagulated. METHODS: We analyzed data pertaining to consecutive AF patients admitted over a 6-year period with acute MCA territory infarcts. We divided the patients according to DWI (diffusion-weighted imaging) lesion volumes and patterns, and the relationship between stroke predictors (the CHADS2 and CHA2DS2-VASc score), systemic, and local factors and each stroke phenotype were then evaluated. RESULTS: The stroke phenotypes varied among 231 patients (admission INR median 1.06, interquartile range (IQR) 1.00-1.14). Specifically, (1) the DWI lesion volumes ranged from 0.04-338.62 ml (median 11.86 ml; IQR, 3.07-44.20 ml) and (2) 46 patients had a territorial infarct pattern, 118 had a lobar/deep pattern and 67 had a small scattered pattern. Multivariate testing revealed that the CHADS2 and CHA2DS2-VASc score were not related to either stroke phenotype. Additionally, the prior use of antiplatelet agents was not related to the stroke phenotypes. Congestive heart failure and diastolic dysfunction were not associated with stroke phenotypes. CONCLUSIONS: The results of this study indicated that the determinants of stroke phenotypes were different from the predictors (i.e., CHADS2 and CHA2DS2-VASc score) of stroke in patients with AF. FAU - Oh, Semi AU - Oh S AD - Department of Neurology, Stroke and Cerebrovascular Centre, Samsung Medical Centre, Sungkyunkwan University, South Korea. FAU - Kim, Suk Jae AU - Kim SJ FAU - Ryu, Soo-Kyoung AU - Ryu SK FAU - Kim, Gyeong-Moon AU - Kim GM FAU - Chung, Chin Sang AU - Chung CS FAU - Lee, Kwang Ho AU - Lee KH FAU - Bang, Oh Young AU - Bang OY LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20110824 PL - England TA - BMC Neurol JT - BMC neurology JID - 100968555 RN - 0 (Anticoagulants) SB - IM MH - Aged MH - Anticoagulants/therapeutic use MH - Atrial Fibrillation/*complications/drug therapy MH - Brain/pathology MH - Diffusion Magnetic Resonance Imaging/methods/statistics & numerical data MH - Female MH - Humans MH - International Normalized Ratio MH - Male MH - Middle Aged MH - Phenotype MH - Predictive Value of Tests MH - Risk Factors MH - *Severity of Illness Index MH - Stroke/complications/*diagnosis/drug therapy/pathology PMC - PMC3174877 EDAT- 2011/08/25 06:00 MHDA- 2012/01/24 06:00 PMCR- 2011/08/24 CRDT- 2011/08/25 06:00 PHST- 2011/06/09 00:00 [received] PHST- 2011/08/24 00:00 [accepted] PHST- 2011/08/25 06:00 [entrez] PHST- 2011/08/25 06:00 [pubmed] PHST- 2012/01/24 06:00 [medline] PHST- 2011/08/24 00:00 [pmc-release] AID - 1471-2377-11-107 [pii] AID - 10.1186/1471-2377-11-107 [doi] PST - epublish SO - BMC Neurol. 2011 Aug 24;11:107. doi: 10.1186/1471-2377-11-107.